| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Radiation Oncology Branch [S. M. H., Z. T., C. M. K., J. G., L. W., M. S., E. G., J. B. M., A. R.] and Biostatistics and Data Management Section [D. V.], National Cancer Institute, NIH, Bethesda, Maryland 20892 and Molecular Biology, Hebrew University Medical School, Jerusalem 91010, Israel [A. S.]
Nitroxide compounds are stable free radicals which were previously investigated as hypoxic cell radiosensitizers. The stable nitroxide 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (Tempol) has recently been shown to protect aerated cells in culture against superoxide generated from hypoxanthine/xanthine oxidase, hydrogen peroxide, and radiation-induced cytotoxicity and to modestly sensitize hypoxic cultured cells. To extend these observations from the cellular level to the whole animal, the toxicity, pharmacology, and in vivo radioprotective effects of Tempol were studied in C3H mice. The maximum tolerated dose of Tempol administered i.p. was found to be 275 mg/kg, which resulted in maximal Tempol levels in whole blood 5–10 min after injection. Mice were exposed to whole-body radiation in the absence or presence of injected Tempol (275 mg/kg) 5–10 min after administration. Tempol treatment provided significant radioprotection (P < 0.0001); the dose of radiation at which 50% of Tempol-treated mice die at 30 days was 9.97 Gy, versus 7.84 Gy for control mice. Tempol represents a new class of in vivo, non-sulfurcontaining radiation protectors. Given the potential for hypoxic radiosensitization and serobic cell radioprotection, Tempol or other analogues may have potential therapeutic application.
1 Supported in part by Grant 89-00124 from the United States-Israel Binational Science Foundation, Jerusalem.
2 To whom requests for reprints should be addressed, at Radiation Oncology Branch/National Cancer Institute, Building 10, Room B3-B69, Bethesda, MD 20892.
Received 9/30/91. Accepted 1/24/92.
This article has been cited by other articles:
|
|
 |
|
  M. S. RAJAGOPALAN, K. GUPTA, M. W. EPPERLY, D. FRANICOLA, X. ZHANG, H. WANG, H. ZHAO, V. A. TYURIN, J. G. PIERCE, V. E. KAGAN, et al. The Mitochondria-targeted Nitroxide JP4-039 Augments Potentially Lethal Irradiation Damage Repair In Vivo, September 1, 2009; 23(5): 717 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Wilcox and A. Pearlman Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-S. Zhang, L. Eaton, E. R. Snyder, S. Houghtaling, J. B. Mitchell, M. Finegold, C. Van Waes, and M. Grompe Tempol Protects against Oxidative Damage and Delays Epithelial Tumor Onset in Fanconi Anemia Mice Cancer Res., March 1, 2008; 68(5): 1601 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Soule, J. M. Brown, N. M. Kushnir-Sukhov, N. L. Simone, J. B. Mitchell, and D. D. Metcalfe Effects of Gamma Radiation on Fc{epsilon}RI and TLR-Mediated Mast Cell Activation J. Immunol., September 1, 2007; 179(5): 3276 - 3286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Cotrim, F. Hyodo, K.-I. Matsumoto, A. L. Sowers, J. A. Cook, B. J. Baum, M. C. Krishna, and J. B. Mitchell Differential Radiation Protection of Salivary Glands versus Tumor by Tempol with Accompanying Tissue Assessment of Tempol by Magnetic Resonance Imaging Clin. Cancer Res., August 15, 2007; 13(16): 4928 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jiang, I. Kurnikov, N. A. Belikova, J. Xiao, Q. Zhao, A. A. Amoscato, R. Braslau, A. Studer, M. P. Fink, J. S. Greenberger, et al. Structural Requirements for Optimized Delivery, Inhibition of Oxidative Stress, and Antiapoptotic Activity of Targeted Nitroxides J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1050 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Reliene and R. H. Schiestl Antioxidants Suppress Lymphoma and Increase Longevity in Atm-Deficient Mice J. Nutr., January 1, 2007; 137(1): 229S - 232S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-i. Matsumoto, F. Hyodo, A. Matsumoto, A. P. Koretsky, A. L. Sowers, J. B. Mitchell, and M. C. Krishna High-Resolution Mapping of Tumor Redox Status by Magnetic Resonance Imaging Using Nitroxides as Redox-Sensitive Contrast Agents Clin. Cancer Res., April 15, 2006; 12(8): 2455 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Cotrim, A. L. Sowers, B. M. Lodde, J. M. Vitolo, A. Kingman, A. Russo, J. B. Mitchell, and B. J. Baum Kinetics of Tempol for Prevention of Xerostomia Following Head and Neck Irradiation in a Mouse Model Clin. Cancer Res., October 15, 2005; 11(20): 7564 - 7568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pervan, K. S. Iwamoto, and W. H. McBride Proteasome Structures Affected by Ionizing Radiation Mol. Cancer Res., July 1, 2005; 3(7): 381 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Welch, J. Blau, H. Xie, T. Chabrashvili, and C. S. Wilcox Angiotensin-induced defects in renal oxygenation: role of oxidative stress Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H22 - H28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Metz, D. Smith, R. Mick, R. Lustig, J. Mitchell, M. Cherakuri, E. Glatstein, and S. M. Hahn A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy Clin. Cancer Res., October 1, 2004; 10(19): 6411 - 6417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schubert, L. Erker, C. Barlow, H. Yakushiji, D. Larson, A. Russo, J. B. Mitchell, and A. Wynshaw-Boris Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice Hum. Mol. Genet., August 15, 2004; 13(16): 1793 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Lee, I. S. Kim, and J.-W. Park The use of N-t-butyl hydroxylamine for radioprotection in cultured cells and mice Carcinogenesis, August 1, 2004; 25(8): 1435 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishiyama, L. Yao, Y. Nagai, K. Miyata, M. Yoshizumi, S. Kagami, S. Kondo, H. Kiyomoto, T. Shokoji, S. Kimura, et al. Possible Contributions of Reactive Oxygen Species and Mitogen-Activated Protein Kinase to Renal Injury in Aldosterone/Salt-Induced Hypertensive Rats Hypertension, April 1, 2004; 43(4): 841 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Vitolo, A. P. Cotrim, A. L. Sowers, A. Russo, R. B. Wellner, S. R. Pillemer, J. B. Mitchell, and B. J. Baum The Stable Nitroxide Tempol Facilitates Salivary Gland Protection during Head and Neck Irradiation in a Mouse Model Clin. Cancer Res., March 1, 2004; 10(5): 1807 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Lee and J.-W. Park Protective Role of {alpha}-Phenyl-N-t-butylnitrone against Ionizing Radiation in U937 Cells and Mice Cancer Res., October 15, 2003; 63(20): 6885 - 6893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Meng, G. W. Cason, A. W. Gannon, L. C. Racusen, and R. D. Manning Jr Oxidative Stress in Dahl Salt-Sensitive Hypertension Hypertension, June 1, 2003; 41(6): 1346 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kawada, E. Imai, A. Karber, W. J. Welch, and C. S. Wilcox A Mouse Model of Angiotensin II Slow Pressor Response: Role of Oxidative Stress J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2860 - 2868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Mitchell, M. C. Krishna, P. Kuppusamy, J. A. Cook, and A. Russo Protection Against Oxidative Stress by Nitroxides Experimental Biology and Medicine, July 1, 2001; 226(7): 620 - 621. [Full Text]
|
|
|
|
 |
|
 P. A. Lapchak, D. F. Chapman, and J. A. Zivin Pharmacological Effects of the Spin Trap Agents N-t-Butyl-Phenylnitrone (PBN) and 2,2,6,6-Tetramethylpiperidine-N-Oxyl (TEMPO) in a Rabbit Thromboembolic Stroke Model : Combination Studies With the Thrombolytic Tissue Plasminogen Activator Stroke, January 1, 2001; 32(1): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Shankar, K. Hideg, J. L. Zweier, and P. Kuppusamy Targeted Antioxidant Properties of N-[(Tetramethyl-3-pyrroline-3-carboxamido)propyl]phthalimide and Its Nitroxide Metabolite in Preventing Postischemic Myocardial Injury J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 838 - 845. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Suy, J. B. Mitchell, D. Ehleiter, A. Haimovitz-Friedman, and U. Kasid Nitroxides Tempol and Tempo Induce Divergent Signal Transduction Pathways in MDA-MB 231 Breast Cancer Cells J. Biol. Chem., July 10, 1998; 273(28): 17871 - 17878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Schnackenberg, W. J. Welch, and C. S. Wilcox Normalization of Blood Pressure and Renal Vascular Resistance in SHR With a Membrane-Permeable Superoxide Dismutase Mimetic : Role of Nitric Oxide Hypertension, July 1, 1998; 32(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Krishna, A. Samuni, J. Taira, S. Goldstein, J. B. Mitchell, and A. Russo Stimulation by Nitroxides of Catalase-like Activity of Hemeproteins. KINETICS AND MECHANISM J. Biol. Chem., October 18, 1996; 271(42): 26018 - 26025. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
